Woodmont Investment Counsel LLC Harrow Health, Inc. Transaction History
Woodmont Investment Counsel LLC
- $1.36 Billion
- Q1 2025
A detailed history of Woodmont Investment Counsel LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Woodmont Investment Counsel LLC holds 103,693 shares of HROW stock, worth $2.67 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
103,693
Previous 81,400
27.39%
Holding current value
$2.67 Million
Previous $2.73 Million
1.03%
% of portfolio
0.2%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$102 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$55.3 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$48.6 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$48 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$24.6 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $697M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...